Mowery & Schoenfeld Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Mowery & Schoenfeld Wealth Management's PFE Position: Q1 2026 in Review
Mowery & Schoenfeld Wealth Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 63 shares — an estimated $1.57K sold.
Mowery & Schoenfeld Wealth Management first reported a position in PFE in Q4 2023 and held it in 7 quarters. The position peaked at $37.5K in Q4 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Mowery & Schoenfeld Wealth Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Mowery & Schoenfeld Wealth Management sold 63 Pfizer shares in Q1 2026, an estimated $1.57K.
- Mowery & Schoenfeld Wealth Management first reported a position in Pfizer in Q4 2023 and held it in 7 quarters.
- Mowery & Schoenfeld Wealth Management's Pfizer position peaked at $37.5K in Q4 2024.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.